Form D · Venture Capital Fund
Biovance Capital Fund I - Fundo de Capital de Risco Fechado
Lisbon, S1 · CIK 0002018395
Offering snapshot reported Apr 12, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $65M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $270K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-510486
US Dollar amounts are approximate and rounded to the nearest million, based on a 60 million EUR cap. Calculated using the EUR to USD exchange rate as of April 9, 2024.
Source: Form D, filed Apr 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joao Manuel Da Silva Santos Botelho | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
Estrada Do Paco Do Lumiar Campus Do Lumiar, Edificio R
Lisbon, S1, 1649-038
Lisbon, S1, 1649-038